OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Centrally Acting Agents for Obesity: Past, Present, and Future
Ann A. Coulter, Candida J. Rebello, Frank L. Greenway
Drugs (2018) Vol. 78, Iss. 11, pp. 1113-1132
Open Access | Times Cited: 121
Ann A. Coulter, Candida J. Rebello, Frank L. Greenway
Drugs (2018) Vol. 78, Iss. 11, pp. 1113-1132
Open Access | Times Cited: 121
Showing 1-25 of 121 citing articles:
Long-Term Efficacy and Safety of Anti-Obesity Treatment: Where Do We Stand?
Young Jin Tak, Sang Yeoup Lee
Current Obesity Reports (2021) Vol. 10, Iss. 1, pp. 14-30
Open Access | Times Cited: 261
Young Jin Tak, Sang Yeoup Lee
Current Obesity Reports (2021) Vol. 10, Iss. 1, pp. 14-30
Open Access | Times Cited: 261
Pharmacotherapy of obesity: Available medications and drugs under investigation
Eleni Pilitsi, Olivia M. Farr, Stergios A. Pοlyzos, et al.
Metabolism (2018) Vol. 92, pp. 170-192
Open Access | Times Cited: 229
Eleni Pilitsi, Olivia M. Farr, Stergios A. Pοlyzos, et al.
Metabolism (2018) Vol. 92, pp. 170-192
Open Access | Times Cited: 229
Semaglutide 2.4 mg for the Treatment of Obesity: Key Elements of the STEP Trials 1 to 5
Robert F. Kushner, Salvatore Calanna, Melanie J. Davies, et al.
Obesity (2020) Vol. 28, Iss. 6, pp. 1050-1061
Open Access | Times Cited: 212
Robert F. Kushner, Salvatore Calanna, Melanie J. Davies, et al.
Obesity (2020) Vol. 28, Iss. 6, pp. 1050-1061
Open Access | Times Cited: 212
Melanocortin-4 Receptor Signalling: Importance for Weight Regulation and Obesity Treatment
Peter Kühnen, Heiko Krude, Heike Biebermann
Trends in Molecular Medicine (2019) Vol. 25, Iss. 2, pp. 136-148
Closed Access | Times Cited: 152
Peter Kühnen, Heiko Krude, Heike Biebermann
Trends in Molecular Medicine (2019) Vol. 25, Iss. 2, pp. 136-148
Closed Access | Times Cited: 152
Selection of Antiobesity Medications Based on Phenotypes Enhances Weight Loss: A Pragmatic Trial in an Obesity Clinic
Andrés Acosta, Michael Camilleri, Barham Abu Dayyeh, et al.
Obesity (2021) Vol. 29, Iss. 4, pp. 662-671
Open Access | Times Cited: 124
Andrés Acosta, Michael Camilleri, Barham Abu Dayyeh, et al.
Obesity (2021) Vol. 29, Iss. 4, pp. 662-671
Open Access | Times Cited: 124
Gut liver brain axis in diseases: the implications for therapeutic interventions
Mengyao Yan, Shuli Man, Benyue Sun, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 86
Mengyao Yan, Shuli Man, Benyue Sun, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 86
The Role of Glp-1 Receptor Agonists in Insulin Resistance with Concomitant Obesity Treatment in Polycystic Ovary Syndrome
Krzysztof Bednarz, Karolina Kowalczyk, Marlena Cwynar, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 8, pp. 4334-4334
Open Access | Times Cited: 78
Krzysztof Bednarz, Karolina Kowalczyk, Marlena Cwynar, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 8, pp. 4334-4334
Open Access | Times Cited: 78
GLP-1 Receptor Agonist Use and Risk of Suicide Death
Peter Ueda, Jonas Söderling, Viktor Wintzell, et al.
JAMA Internal Medicine (2024)
Open Access | Times Cited: 18
Peter Ueda, Jonas Söderling, Viktor Wintzell, et al.
JAMA Internal Medicine (2024)
Open Access | Times Cited: 18
Anti-Obesity Drugs: Long-Term Efficacy and Safety: An Updated Review
Young Jin Tak, Sang Yeoup Lee
The World Journal of Men s Health (2020) Vol. 39, Iss. 2, pp. 208-208
Open Access | Times Cited: 130
Young Jin Tak, Sang Yeoup Lee
The World Journal of Men s Health (2020) Vol. 39, Iss. 2, pp. 208-208
Open Access | Times Cited: 130
Semaglutide as a promising antiobesity drug
Georgios A. Christou, Niki Katsiki, John E. Blundell, et al.
Obesity Reviews (2019) Vol. 20, Iss. 6, pp. 805-815
Closed Access | Times Cited: 124
Georgios A. Christou, Niki Katsiki, John E. Blundell, et al.
Obesity Reviews (2019) Vol. 20, Iss. 6, pp. 805-815
Closed Access | Times Cited: 124
Adipose tissue, systematic inflammation, and neurodegenerative diseases
Ludovico Migliolo, AnaPaula de A. Boleti, Pedro Henrique de Oliveira Cardoso, et al.
Neural Regeneration Research (2022) Vol. 18, Iss. 1, pp. 38-38
Open Access | Times Cited: 46
Ludovico Migliolo, AnaPaula de A. Boleti, Pedro Henrique de Oliveira Cardoso, et al.
Neural Regeneration Research (2022) Vol. 18, Iss. 1, pp. 38-38
Open Access | Times Cited: 46
Treatment of Acquired Hypothalamic Obesity: Now and the Future
Paul Dimitri
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 41
Paul Dimitri
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 41
Role of diet and exercise in aging, Alzheimer’s disease, and other chronic diseases
Sachi Khemka, Aananya Reddy, Ricardo Isaiah Garcia, et al.
Ageing Research Reviews (2023) Vol. 91, pp. 102091-102091
Closed Access | Times Cited: 38
Sachi Khemka, Aananya Reddy, Ricardo Isaiah Garcia, et al.
Ageing Research Reviews (2023) Vol. 91, pp. 102091-102091
Closed Access | Times Cited: 38
Role of lifestyle and glucagon‐like peptide‐1 receptor agonists for weight loss in obesity, type 2 diabetes and steatotic liver diseases
Anna Giannakogeorgou, Michael Roden
Alimentary Pharmacology & Therapeutics (2024) Vol. 59, Iss. S1
Open Access | Times Cited: 12
Anna Giannakogeorgou, Michael Roden
Alimentary Pharmacology & Therapeutics (2024) Vol. 59, Iss. S1
Open Access | Times Cited: 12
TAAR1 agonists improve glycemic control, reduce body weight and modulate neurocircuits governing energy balance and feeding
Nina Dedic, Lien Wang, Éva Hajós‐Korcsok, et al.
Molecular Metabolism (2024) Vol. 80, pp. 101883-101883
Open Access | Times Cited: 8
Nina Dedic, Lien Wang, Éva Hajós‐Korcsok, et al.
Molecular Metabolism (2024) Vol. 80, pp. 101883-101883
Open Access | Times Cited: 8
Obesity medications in development
Candida J. Rebello, Frank L. Greenway
Expert Opinion on Investigational Drugs (2019) Vol. 29, Iss. 1, pp. 63-71
Open Access | Times Cited: 58
Candida J. Rebello, Frank L. Greenway
Expert Opinion on Investigational Drugs (2019) Vol. 29, Iss. 1, pp. 63-71
Open Access | Times Cited: 58
New insights into potential nutritional effects of dietary saponins in protecting against the development of obesity
Syam Praveen Kumar Jeepipalli, Bin Du, Uteuliyev Yerzhan Sabitaliyevich, et al.
Food Chemistry (2020) Vol. 318, pp. 126474-126474
Closed Access | Times Cited: 53
Syam Praveen Kumar Jeepipalli, Bin Du, Uteuliyev Yerzhan Sabitaliyevich, et al.
Food Chemistry (2020) Vol. 318, pp. 126474-126474
Closed Access | Times Cited: 53
Whole-brain activation signatures of weight-lowering drugs
Henrik H. Hansen, Johanna Perens, Urmas Roostalu, et al.
Molecular Metabolism (2021) Vol. 47, pp. 101171-101171
Open Access | Times Cited: 51
Henrik H. Hansen, Johanna Perens, Urmas Roostalu, et al.
Molecular Metabolism (2021) Vol. 47, pp. 101171-101171
Open Access | Times Cited: 51
Hypothalamic control of interoceptive hunger
Justin N. Siemian, Miguel Arenivar, Sarah Sarsfield, et al.
Current Biology (2021) Vol. 31, Iss. 17, pp. 3797-3809.e5
Open Access | Times Cited: 48
Justin N. Siemian, Miguel Arenivar, Sarah Sarsfield, et al.
Current Biology (2021) Vol. 31, Iss. 17, pp. 3797-3809.e5
Open Access | Times Cited: 48
The incretin/glucagon system as a target for pharmacotherapy of obesity
Stefano Del Prato, Baptist Gallwitz, Jens J. Holst, et al.
Obesity Reviews (2021) Vol. 23, Iss. 2
Open Access | Times Cited: 46
Stefano Del Prato, Baptist Gallwitz, Jens J. Holst, et al.
Obesity Reviews (2021) Vol. 23, Iss. 2
Open Access | Times Cited: 46
Review article: role of glucagon‐like peptide‐1 receptor agonists in non‐alcoholic steatohepatitis, obesity and diabetes—what hepatologists need to know
A. Sidney Barritt, Emma Marshman, Mazen Noureddin
Alimentary Pharmacology & Therapeutics (2022) Vol. 55, Iss. 8, pp. 944-959
Open Access | Times Cited: 28
A. Sidney Barritt, Emma Marshman, Mazen Noureddin
Alimentary Pharmacology & Therapeutics (2022) Vol. 55, Iss. 8, pp. 944-959
Open Access | Times Cited: 28
Jeremy Pomeroy, Anthony D. Krentz, Jesse G. Richardson, et al.
Pediatric Obesity (2020) Vol. 16, Iss. 2
Open Access | Times Cited: 47
Dairy-derived peptides for satiety
Alina Kondrashina, André Brodkorb, Linda Giblin
Journal of Functional Foods (2020) Vol. 66, pp. 103801-103801
Open Access | Times Cited: 40
Alina Kondrashina, André Brodkorb, Linda Giblin
Journal of Functional Foods (2020) Vol. 66, pp. 103801-103801
Open Access | Times Cited: 40
Molecular Imaging of Central Dopamine in Obesity: A Qualitative Review across Substrates and Radiotracers
Lieneke Janssen, Annette Horstmann
Brain Sciences (2022) Vol. 12, Iss. 4, pp. 486-486
Open Access | Times Cited: 26
Lieneke Janssen, Annette Horstmann
Brain Sciences (2022) Vol. 12, Iss. 4, pp. 486-486
Open Access | Times Cited: 26
Uncovering CNS access of lipidated exendin-4 analogues by quantitative whole-brain 3D light sheet imaging
Grethe Skovbjerg, Urmas Roostalu, Casper G. Salinas, et al.
Neuropharmacology (2023) Vol. 238, pp. 109637-109637
Closed Access | Times Cited: 14
Grethe Skovbjerg, Urmas Roostalu, Casper G. Salinas, et al.
Neuropharmacology (2023) Vol. 238, pp. 109637-109637
Closed Access | Times Cited: 14
